Skip to main content

Table 1 Demographics and ocular characteristics

From: Choroidal manifestations of non-ocular sarcoidosis: an enhanced depth imaging OCT study

 

Control

(mean ± SD or N [%])

Non-ocular sarcoidosis

(mean ± SD or N [%])

p

Number of eyes

30 eyes of 30 patients

30 eyes of 30 patients

 

Demographics

 Age, years

56.00 ± 11.66

55.13 ± 11.58

0.874

 Sex, Male

11 (36.66)

11 (36.66)

1.000

  Female

19 (63.33)

19 (63.33)

 

 Subtypes of sarcoidosis

 

Pulmonary (27 [90]), Extrapulmonary; skin (3 [10])

 

 Duration of sarcoidosis, months

 

16.10 ± 26.18

 

 Treatment regimen

 

Prednisolone (6 [20]),

MTX (5 [16.66]),

Observation (19 [63.63])

 

 ACE, U/L

 

51.55 ± 21.77

 

 CRP, mg/dL

 

0.20 ± 0.16

 

Ocular characteristics

 BCVA, logMAR

0.02 ± 0.04

0.03 ± 0.05

0.152

 SE, Diopters

-0.80 ± 1.81

-0.71 ± 1.93

0.837

 IOP, mmHg

16.06 ± 1.96

15.73 ± 2.40

0.559

  1. SD Standard deviation, MTX methotrexate, ACE angiotensin converting enzyme, CRP C-reactive protein, BCVA best corrected visual acuity, SE spherical equivalent, IOP intraocular pressure, SLCC Sattler layer-choriocapillaris complex, HL Haller layer